US Physical Therapy Names Nchacha Etta as CFO Effective September 1

Management

โดย Insider Monkey·

Summary · why it matters

US Physical Therapy announced on August 14 that Nchacha Etta will become its Executive Vice President and Chief Financial Officer, effective September 1, closing a search that began after Jason Curtis stepped in as interim CFO on April 24. Etta most recently served as Executive Vice President and Chief Financial Officer of Omnicell from 2023 to 2025, and previously held CFO roles at Essilor of America, a subsidiary of EssilorLuxottica, and at Johnson & Johnson Vision, after nine years in senior finance roles at The Coca-Cola Company and earlier stops at Microsoft, Eli Lilly, and The Carlyle Group. He inherits a company that grew total net revenue 8.5% to $214.1 million in the second quarter of 2026, closed three acquisitions this year for a combined $37.6 million, and reaffirmed full-year adjusted EBITDA guidance of $102 million to $106 million. Net income attributable to USPH shareholders fell to $9.9 million in the second quarter of 2026 from $12.4 million a year earlier, with EPS dropping to $0.25 from $0.58, while physical therapy margin slipped to 19.5% from 21.2% partly on about 100 basis points of pressure from company-provided health benefit costs. Cash and cash equivalents dropped to $24.9 million as of June 30 from $35.6 million at the end of 2025, and borrowings under the company's credit facility climbed to $221 million from $161.8 million, following an April 14 refinancing into a $450 million, five-year credit facility.

U.S. Physical Therapy, Inc. ±

Impact on stocks 8

Health Care▲ · 2 stocks

U.S. Physical Therapy, Inc.

USPH

± MixedCapitalrelevance

USPH names Nchacha Etta as new CFO effective September 1, closing a search that began after an interim CFO stepped in; a leadership change with no clear directional signal.